FDB to stop increasing counterfeiting of medicines
The Food and Drugs Board, FDB, is considering the introduction of a new technology that will detect fake drug products from genuine ones. The technology will indicate codes on the products which will be verified later from the manufacturers. The Acting Deputy Chief Executive of the Board, Rev. Jonathan Martey, announced this in Accra at a stakeholders forum on global Partnership for Safe Medicines.
10 September 2008